Document is current
Any future updates will be listed below
-
Authors
Thirion, Florence
Sellebjerg, Finn
Fan, Yong
Lyu, Liwei
Hansen, Tue H.
Pons, Nicolas
Levenez, Florence
Quinquis, Benoit
Stankevic, Evelina
Søndergaard, Helle B.
Dantoft, Thomas M.
Poulsen, Casper S.
Forslund, Sofia K.
Vestergaard, Henrik
Hansen, Torben
Brix, Susanne
Oturai, Annette
Sørensen, Per Soelberg
Ehrlich, Stanislav D.
Pedersen, Oluf http://orcid.org/0000-0002-3321-3972
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden
Metagenopolis grant (ANR-11-DPBS-0001)
Danish Multiple Sclerosis Society
- License Information
-
More Information
Article History
Received: 23 May 2022
Accepted: 7 December 2022
First Online: 5 January 2023
Declarations
:
: The study protocol involving multiple sclerosis cases and HC was approved by the Ethical Committees of the Capital Region of Denmark (Protocol no.: H-4-2012-176).) The DanFunD study was also approved by the Ethical Committees of the Capital Region of Denmark (H-3-2012-015), and the CBMR study was approved by the Ethical Committees of the Capital Region of Denmark (H-3-2012-145). All studies were conducted in accordance with the Helsinki Declaration. Written informed consent was obtained from all study participants.
: Not applicable.
: The authors declare that they have no competing interests.
